What Does Alexandria Real Estate (ARE) Do? – Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Overview
ARE (Alexandria Real Estate) is a US REIT that leases life-science research laboratory offices, with biopharmaceutical R&D leasing demand, occupancy and rental rates, interest rates and dividends, and the growth in laboratory supply identified as the key drivers of its earnings and stock outlook.
Subscribe🏢 What kind of company is ARE (Alexandria Real Estate)?
ARE (Alexandria Real Estate) is a US real estate investment trust (REIT) that owns and leases research laboratory (lab) offices for life-science companies, including pharmaceutical and biotech firms. It is a life-science-focused REIT supplying offices equipped with specialized research facilities in major biotech cluster regions.
The majority of its revenue is generated from life-science research laboratory office rental income. Because laboratories require specialized infrastructure, the barriers to entry are higher than for ordinary offices, and its locations within biotech clusters are a key competitive strength. Biopharmaceutical R&D investment and leasing demand, occupancy rates, and rental rates drive earnings, while the REIT structure returns a significant portion of profits as dividends.
How does ARE (Alexandria Real Estate) make money?| Business Segment | Revenue Share | Description | ||||||
|---|---|---|---|---|---|---|---|---|
| Research Laboratory Office Leasing | Core | Core segment accounting for the majority of revenue through life-science research laboratory office rental income | ||||||
| Biotech Cluster Locations | Growth Foundation | Specialized facility locations within major biotech clusters | ||||||
| Rental Rates & Occupancy | Revenue Base | Rental rate increases and occupancy |
1-Year Price Performance
52-Week Price Range
Competitors| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
 BXP | BXP Inc | $63.72 | -0.9% | $11.1B | 34.2 | 2.0 | 5.69% | 4.4% |
 KRC | Kilroy Realty Corp | $34.85 | -1.2% | $4.1B | 24.5 | 0.8 | 3.19% | 6.21% |
 CUZ | Cousins Properties Inc | $27.94 | +0.1% | $4.6B | 714.6 | 1.0 | 0.14% | 4.61% |
✅ ARE (Alexandria Real Estate) Investor Checklist
ARE (Alexandria Real Estate) is a US REIT that leases life-science research laboratory offices, with high-barrier locations and biotech leasing demand serving as attractions, but biotech funding conditions and interest-rate variables should be reviewed together.
| Checklist | What to Confirm | Current Status |
|---|---|---|
| 🔬 Laboratory Leasing | Research laboratory office rental rates and occupancy | Earnings core |
| 🧫 Biotech Demand | Biopharmaceutical R&D investment and leasing demand | Demand variable |
| 💰 Dividends & Interest Rates | Dividend trajectory and interest-rate-driven interest burden | Interest-rate sensitive |
Weakening leasing demand from a downturn in biotech funding, increased laboratory supply, and interest-rate-driven interest and valuation burdens could affect earnings and dividend capacity, making it necessary to review rental rates, occupancy, biotech leasing demand, and interest-rate conditions together.
ARE (Alexandria Real Estate) is a US life-science REIT equipped with high-barrier laboratory locations and biotech leasing demand, but given biotech funding conditions, supply growth, and interest-rate sensitivity variables, a medium- to long-term perspective is advisable.
Subscribe
Today's 5 AI picks, all free